Blog

The key to seamless reconciliation is ensuring drug accountability. See how a site-based approach can reduce close out timelines and improve data accuracy.

CSPs should be empowered with a good level of understanding what variables or information is critical to model supply planning (feasibility planning to study planning) so they can react and make decisions more effectively.

Transitioning from traditional data servers to the cloud can lead to improved RTSM quality and more enhanced data security. See how!

Over the life of a study, the amount of time and resources spent on changes to a system can significantly impact the study – but do they have to?

An RTSM has critical functions with direct patient impact. As trials grow in complexity, adopting modern tech is inevitable for companies hoping to keep up.

4G Clinical partnered with SCRS to host their first Site Advisory Group for RTSM/IRT systems, where sites and sponsors gathered to discuss, among many other topics, what sites want from their IRT/RTSM.

Did you know that Phase 1 trials can be even more complex than their Phase 2 and 3 counterparts? Don't let scale be the determining factor in choosing to leverage an RTSM. Here are 5 questions to ask when you consider an RTSM for your next Phase 1 study.

4G Clinical partnered with SCRS to host their first Site Advisory Group for RTSM/IRT systems, where sites and sponsors gathered to discuss, among many other topics, how sponsors can become more site-centric.

Having an IRT/RTSM for your IITs will help with supply chain management since IITs traditionally draw from the same pool of drugs as manufacturer-sponsored studies. See how.